23. Share Capital and Other Reserves
|
December 31 |
|
---|---|---|
(thousands of €) |
2024 |
2023 |
On January 1 |
293,937 |
293,604 |
Share capital increase |
- |
333 |
Share capital on December 31 |
293,937 |
293,937 |
|
|
|
Aggregate share capital |
356,445 |
356,445 |
Costs of capital increase (accumulated) |
(62,507) |
(62,507) |
Share capital on December 31 |
293,937 |
293,937 |
History of share capital
The history of the share capital of Galapagos NV between January 1, 2023 and December 31, 2024 is as follows:
Date |
Share capital |
Number of shares |
Aggregate number |
Aggregate share |
---|---|---|---|---|
January 1, 2023 |
|
|
65,836 |
356,112 |
March 20, 2023 |
333 |
62 |
|
|
December 31, 2023 |
|
|
65,897 |
356,445 |
|
|
|
|
|
December 31, 2024 |
|
|
65,897 |
356,445 |
On December 31, 2024, Galapagos NV’s share capital amounted to €356,445 thousand, represented by 65,897,071 shares. All shares were issued, fully paid up and of the same class. The shares have a par value of €5.41 per share.
All of the share issuances listed above were for cash consideration.
The below table summarizes our capital increase for the year 2023. There were no capital increases in 2024.
(thousands of €, except share data) |
Number of |
Share capital |
Share premium |
Share capital and |
Average exercise price subscription rights |
Closing share price on date of capital increase |
---|---|---|---|---|---|---|
On January 1, 2023 |
65,835,511 |
293,604 |
2,735,557 |
3,029,162 |
|
|
|
|
|
|
|
|
|
March 20, 2023: |
61,560 |
333 |
1,437 |
1,770 |
28.75 |
35.47 |
|
|
|
|
|
|
|
On December 31, 2023 |
65,897,071 |
293,937 |
2,736,994 |
3,030,931 |
|
|
|
|
|
|
|
|
|
On December 31, 2024 |
65,897,071 |
293,937 |
2,736,994 |
3,030,931 |
|
|
The Board of Directors is authorized for a period of five years starting from the date of publication in the Annexes to the Belgian State Gazette of the shareholders’ resolution that granted the renewed authorization to increase the share capital of Galapagos NV within the framework of the authorized capital through contributions in kind or in cash.
When increasing the share capital within the limits of the authorized capital, the Board of Directors may, if in Galapagos NV’s interest, restrict or cancel the shareholders’ preferential subscription rights, even if such restriction or cancellation is made for the benefit of one or more specific persons other than the employees of the group. Said authorization can be renewed.
The authorization consists of two parts:
- A general authorization for capital increases up to 20% of the share capital at the time of convening the Shareholders’ Meeting of April 30, 2024 (i.e. €71,288,987.72) was renewed and is valid for a period of five years from the date of publication of this renewal in the Annexes to the Belgian State Gazette, which occurred on May 7, 2024. This general authorization will expire on May 6, 2029.
- A specific authorization for capital increases of more than 20% and up to 33% of the share capital at the time of the convening of the Shareholders’ Meeting of April 25, 2017 (i.e. €82,561,764.93), was renewed and is valid for a period of five years from the date of publication of such renewal in the Annexes to the Belgian State Gazette, which occurred on May 31, 2017. This specific part of the authorized capital can, however, only be used in a number of specific circumstances and upon a resolution of the Board of Directors that all Independent Directors (within the meaning of article 7:87 of the Belgian Companies Code and article 3.5 of the 2020 Code) approve. The Board of Directors is currently not authorized to increase the share capital after notification by the FSMA (Financial Services and Markets Authority) of a public takeover bid on Galapagos NV’s shares. The specific authorization expired on May 30, 2022.
As of December 31, 2024, an amount of €63,817,777.72 still remained available under the general part of the authorized capital.
Other reserves
Other reserves at December 31, 2024 was negative for €3.2 million (€5.9 million at December 31, 2023) and was related to fair value adjustments on financial assets held at fair value through other comprehensive income for an amount of €2.5 million (nil at December 31, 2023), and to the re-measurement of the defined benefit obligation for a negative amount of €5.6 million (a negative amount of €5.9 million at December 31, 2023).